A. Bush (London, United Kingdom), M. Goetz (Wien, Austria)
Evaluation of MRP1-5 gene expression in cystic fibrosis patients homozygous for the ΔF508 mutation
I. Hurbain, I. Sermet-Gaudelus, B. Vallee, M. N. Feuillet, G. Lenoir, J. F. Bernaudin, A. Edelman, A. Fajac (Paris, France)
|   |
Metabolic gene polymorphisms (CYP1A1, EPHX1, GSTM1 and GSTP1) associations with the severity of cystic fibfosis airway disease
G. F. Korytina, D. G. Yanbaeva, T. V. Victorova (Ufa, Russia)
| |
Impact of mannose-binding lectin deficiency on clinical course of cystic fibrosis in Southern Italy
F. Cardinale, A. Polizzi, T. Santostasi, A. Manca, G. Iacoviello, M. S. Loffredo, I. Chinellato, A. Dellino, R. Rubino, E. Costantino, N. Rigillo, L. Armenio (Bari, Italy)
| |
No association of angiotensin I-converting enzyme gene polymorphism and pulmonary function in cystic fibrosis
H. Grasemann, W. H. Nikolaizik, R. Büscher, F. Ratjen (Essen, Germany)
| |
Increased binding activity of hypoxia inducible factor (HIF)-1α to vascular endothelial growth factor (VEGF) promoter region mediates enhanced vascular permeability in the lung of cystic fibrosis (CF) patients
K. Krenn, P. Paulus, D. Abraham, S. Aharinejad (Vienna, Austria)
| |
Interleukin-1 receptor antagonist gene polymorphism and Pseudomonas aeruginosa chronic infection in children with cystic fibrosis
K. Chadelat, H. Corvol, C. Flamant, M. Roussey, F. Bremont, A. Flahault, M. C. Miesch, A. Clement, A. Henrion-Caude (Paris, Rennes, Toulouse, France)
| |
Pseudomonas aeruginosa DNA-fingerprinting of colonized CF-patients in a rehabilitation centre: a 2-years survey
S. G. P. Vandaele, P. Schelstraete, F. Haerynck, H. Franckx, G. Claeys, M. Vaneechoutte, F. De Baets (Gent, De Haan, Belgium)
| |
Pseudomonas aeruginosa in public swimming pools and bathroom water taps of patients with cystic fibrosis
J. Barben, G. Hafen, J. Schmid (St. Gallen, Switzerland)
| |